Narrowband UV-B and Psoriasis

Archives of Dermatology

Volumn 133, Issue 12, 1997, Pages 1587-1588

  Stern, Robert S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPARATIVE STUDY; HUMAN; METHODOLOGY; NOTE; PSORIASIS; PUVA;

HUMANS; PSORIASIS; PUVA THERAPY;

EID: 0031306293     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1997.03890480109019     Document Type: Article

References (16)

1. Tanenbaum L, Parrish JA, Pathak MA, Anderson RR, Fitzpatrick TB. Tar phototoxicity and phototherapy for psoriasis. Arch Dermatol. 1975;111:467-470.
2. LeVine MJ, White HA, Parrish JA. Components of the Goeckerman regimen. J Invest Dermatol. 1979;73:170-173.
3. LeVine MJ, Parrish JA. Outpatient phototherapy of psoriasis. Arch Dermatol. 1980; 116:552-554.
4. Adrian RM, Parrish JA, Momtaz-TK, Karlin MJ. Outpatient phototherapy for psoriasis. Arch Dermatol. 1981;117:623-626.
5. Stern RS, Gange RW, Parrish JA, Tang SV, Arndt KA. Contribution of topical tar oil to ultraviolet B phototherapy for psoriasis. J Am Acad Dermatol. 1986;14: 742-747.
6. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol. 1981;76:359-362.
7. van Weelden H, De La Faille HV, Young E, van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol. 1988;119:11-19.
8. Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototherapy: an effective treatment for psoriasis. Br J Dermatol. 1988;119:619-696.
9. Coven TR, Burack LH, Gilleaudeau P, Keogh M, Ozawa M, Krueger JG. Narrow-band UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B. Arch Dermatol. 1997;133:1514-1522.
10. Stern RS. The benefits, costs and risk of topical tar preparations in the treatment of psoriasis: consideration of cost-effectiveness. Ann Acad Med Singapore. 1988;17:473-476.
11. Stern RS, Armstrong RB, Anderson TF, et al. Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study. J Am Acad Dermatol. 1986;15:546-552.
12. Green C, Lakshmipathi T, Johnson BE, Ferguson J. A comparison of the efficacy and relapse rates of narrowband UVB (TL-01) monotherapy vs. etretinate (re-TLI-01) vs. etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients. Br J Dermatol. 1992;127:5-9.
13. Flindt-Hansen H, McFadden N, Larsen TE, Eeg-Larsen T, Thune P. Effect of new narrow-band UVB lamp on photocarcinogenesis in mice. Acta Derm Venereol. 1991;71:245-248.
14. Gibbs NK, Traynor NJ, MacKie RM, Campbell I, Johnson BE, Ferguson J. The phototumorigenic potential of broad-band (270-350 nm) and narrow-band (311-313 nm) phototherapy sources cannot be predicted by their edematogenic potential in hairless mouse skin. J Invest Dermatol. 1995;104:359-363.
15. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis: Photochemotherapy Follow-up Study. Cancer. 1994;73:2759-2764.
16. Stern RS, Nichols KT, Väkevä LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA): the PUVA Follow-up Study. N Engl J Med. 1997;336:1041-1045.